The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.
In the era of treat all, renewed emphasis is needed on the 39% of people living with HIV who start treatment late who are at an increased risk of deaths and opportunistic infections.
In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older